RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Delker, Don A ^a   McGettigan, Brett M ^a,e   Kanth, Priyanka ^a   Pop, Stelian ^a   Neklason, Deborah W ^b   Bronner, Mary P ^a,b   Burt, Randall W ^a,b   Hagedorn, Curt H ^a,b,c,d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALDOB GENE; AQP5 GENE; ARTICLE; BRAF GENE; CELL ADHESION; CELL DIFFERENTIATION; CELL JUNCTION; CELL MATURATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLON POLYPOSIS; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GJB5 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KLK10 GENE; MALE; MUC17 GENE; MYEOV GENE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; REG4 GENE; RNA SEQUENCE; SESSILE SERRATED POLYPOSIS SYNDROME; SIGNAL TRANSDUCTION; VSIG1 GENE; ADENOMA; CLUSTER ANALYSIS; COLON; COLON POLYP; COLON TUMOR; COLONOSCOPY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; SEQUENCE ANALYSIS;

B RAF KINASE; BRAF PROTEIN, HUMAN; CONNEXIN 31.1, HUMAN; GAP JUNCTION PROTEIN; LECTIN; MEMBRANE PROTEIN; MUC17 PROTEIN, HUMAN; MUCIN; REG4 PROTEIN, HUMAN; TUMOR ANTIGEN; VSIG1 PROTEIN, HUMAN;

ADENOMA; AGED; ANTIGENS, NEOPLASM; CLUSTER ANALYSIS; COLON; COLONIC NEOPLASMS; COLONIC POLYPS; COLONOSCOPY; CONNEXINS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MUCINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; SEQUENCE ANALYSIS, RNA;

EID: 84895768701     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088367     Document Type: Article

References (62)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, et al. (2009) American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 104: 739-750.
3. Snover DC, Burt RW, Odze RD (2010) Serrated Polyps of the colon and rectum and serrated polyposos. . Boxman, F T, Hruban, R H, Theise, N D, ed WHO Classification of Tumors of the Digestive System IARC, Lyon: 160-165.
4. Ferrandez A, Samowitz W, DiSario JA, Burt RW (2004) Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol 99: 2012-2018. (Pubitemid 39421248)
5. Schreiner MA, Weiss DG, Lieberman DA (2010) Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology 139: 1497-1502.
6. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM (2003) Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 27: 65-81. (Pubitemid 36014900)
7. Longacre TA, Fenoglio-Preiser CM (1990) Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 14: 524-537. (Pubitemid 20172523)
8. Jass JR (2007) Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50: 113-130.
9. O'Brien MJ (2007) Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 36: 947-968, viii.
10. Kalady MF, Jarrar A, Leach B, LaGuardia L, O'Malley M, et al. (2011) Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum 54: 164-170.
11. Rosty C, Buchanan DD, Walsh MD, Pearson SA, Pavluk E, et al. (2012) Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol 36: 876-882.
12. Makinen MJ (2007) Colorectal serrated adenocarcinoma. Histopathology 50: 131-150.
13. Boparai KS, Dekker E, Polak MM, Musler AR, van Eeden S, et al. (2011) A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome. Am J Pathol 178: 2700-2707.
14. Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VL, et al. (2006) High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131: 1400-1407. (Pubitemid 44708940)
15. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, et al. (2004) BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53: 1137-1144. (Pubitemid 38961968)
16. Iino H, Jass JR, Simms LA, Young J, Leggett B, et al. (1999) DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol 52: 5-9. (Pubitemid 29023500)
17. Jass JR, Iino H, Ruszkiewicz A, Painter D, Solomon MJ, et al. (2000) Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 47: 43-49. (Pubitemid 30430410)
18. Wallace K, Grau MV, Ahnen D, Snover DC, Robertson DJ, et al. (2009) The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev 18: 2310-2317.
19. Walker RG, Landmann JK, Hewett DG, Worthley DL, Buttenshaw RL, et al. (2010) Hyperplastic polyposis syndrome is associated with cigarette smoking, which may be a modifiable risk factor. Am J Gastroenterol 105: 1642-1647.
20. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, et al. (2012) Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 107: 1315-1329; quiz 1314, 1330.
21. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, et al. (2012) Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143: 844-857.
22. Glatz K, Pritt B, Glatz D, Hartmann A, O'Brien MJ, et al. (2007) A multinational, internet-based assessment of observer variability in the diagnosis of serrated colorectal polyps. Am J Clin Pathol 127: 938-945.
23. Wong NA, Hunt LP, Novelli MR, Shepherd NA, Warren BF (2009) Observer agreement in the diagnosis of serrated polyps of the large bowel. Histopathology 55: 63-66.
24. Caruso M, Moore J, Goodall GJ, Thomas M, Phillis S, et al. (2009) Overexpression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Arch 454: 291-302.
25. Gonzalo DH, Lai KK, Shadrach B, Goldblum JR, Bennett AE, et al. (2013) Gene expression profiling of serrated polyps identifies annexin A10 as a marker of a sessile serrated adenoma/polyp. J Pathol 230: 420-429.
26. Oler AJ, Alla RK, Roberts DN, Wong A, Hollenhorst PC, et al. (2010) Human RNA polymerase III transcriptomes and relationships to Pol II promoter chromatin and enhancer-binding factors. Nat Struct Mol Biol 17: 620-628.
27. Papic N, Maxwell CI, Delker DA, Liu S, Heale BS, et al. (2012) RNA-sequencing analysis of 5′ capped RNAs identifies many new differentially expressed genes in acute hepatitis C virus infection. Viruses 4: 581-612.
28. Negash A, Crochet N, Ramos H, Doehle B, Lau D, et al. (2013) IL-1 production through the hepatic macrophage NLRP3 inflammasome links hepatitis C virus infection with liver inflammation and disease. PLoS Pathogens 9: e1003330.
29. Folkers ME, Delker DA, Maxwell CI, Nelson CA, Schwartz JJ, et al. (2011) ENCODE tiling array analysis identifies differentially expressed annotated and novel 5′ capped RNAs in hepatitis C infected liver. PLoS One 6: e14697.
30. Choi YH, Hagedorn CH (2003) Purifying mRNAs with a high-affinity eIF4E mutant identifies the short 3′ poly(A) end phenotype. Proc Natl Acad Sci U S A 100: 7033-7038. (Pubitemid 36706388)
31. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550. (Pubitemid 41528093)
32. Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, et al. (2007) Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5: 1263-1275.
33. Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, et al. (2005) Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 207: 185-198. (Pubitemid 41404149)
34. Chan TL, Zhao W, Leung SY, Yuen ST, Cancer Genome P (2003) BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63: 4878-4881. (Pubitemid 37022620)
35. Byrd JC, Bresalier RS (2004) Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 23: 77-99. (Pubitemid 38221597)
36. Bartley AN, Thompson PA, Buckmeier JA, Kepler CY, Hsu CH, et al. (2010) Expression of gastric pyloric mucin, MUC6, in colorectal serrated polyps. Mod Pathol 23: 169-176.
37. Weiss AA, Babyatsky MW, Ogata S, Chen A, Itzkowitz SH (1996) Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J Histochem Cytochem 44: 1161-1166. (Pubitemid 26337293)
38. Sternberg LR, Byrd JC, Yunker CK, Dudas S, Hoon VK, et al. (1999) Liver colonization by human colon cancer cells is reduced by antisense inhibition of MUC2 mucin synthesis. Gastroenterology 116: 363-371. (Pubitemid 29055359)
39. Resta-Lenert S, Das S, Batra SK, Ho SB (2011) Muc17 protects intestinal epithelial cells from enteroinvasive E. coli infection by promoting epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol 300: G1144-1155.
40. Moniaux N, Junker WM, Singh AP, Jones AM, Batra SK (2006) Characterization of human mucin MUC17. Complete coding sequence and organization. J Biol Chem 281: 23676-23685. (Pubitemid 44274143)
41. Dhar DK, Wang TC, Maruyama R, Udagawa J, Kubota H, et al. (2003) Expression of cytoplasmic TFF2 is a marker of tumor metastasis and negative prognostic factor in gastric cancer. Lab Invest 83: 1343-1352. (Pubitemid 37140319)
42. Bazzoni G (2003) The JAM family of junctional adhesion molecules. Curr Opin Cell Biol 15: 525-530.
43. Scanlan MJ, Ritter G, Yin BW, Williams C Jr, Cohen LS, et al. (2006) Glycoprotein A34, a novel target for antibody-based cancer immunotherapy. Cancer Immun 6: 2.
44. Oidovsambuu O, Nyamsuren G, Liu S, Goring W, Engel W, et al. (2011) Adhesion protein VSIG1 is required for the proper differentiation of glandular gastric epithelia. PLoS One 6: e25908.
45. Ackerman ME, Chalouni C, Schmidt MM, Raman VV, Ritter G, et al. (2008) A33 antigen displays persistent surface expression. Cancer Immunol Immunother 57: 1017-1027.
46. Lazo PA (2007) Functional implications of tetraspanin proteins in cancer biology. Cancer Sci 98: 1666-1677.
47. Ezumi K, Yamamoto H, Murata K, Higashiyama M, Damdinsuren B, et al. (2008) Aberrant expression of connexin 26 is associated with lung metastasis of colorectal cancer. Clin Cancer Res 14: 677-684. (Pubitemid 351231147)
48. Moon C, Soria JC, Jang SJ, Lee J, Obaidul Hoque M, et al. (2003) Involvement of aquaporins in colorectal carcinogenesis. Oncogene 22: 6699-6703. (Pubitemid 37372210)
49. Alexopoulou DK, Papadopoulos IN, Scorilas A (2013) Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer. Clin Biochem.
50. Laiho P, Kokko A, Vanharanta S, Salovaara R, Sammalkorpi H, et al. (2007) Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis. Oncogene 26: 312-320. (Pubitemid 46095743)
51. Pouyet L, Roisin-Bouffay C, Clement A, Millet V, Garcia S, et al. (2010) Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model. Inflamm Bowel Dis 16: 96-104.
52. Planell N, Lozano JJ, Mora-Buch R, Masamunt MC, Jimeno M, et al. (2012) Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations. Gut.
53. Mitani Y, Oue N, Matsumura S, Yoshida K, Noguchi T, et al. (2007) Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy. Oncogene 26: 4383-4393. (Pubitemid 47014457)
54. Bishnupuri KS, Luo Q, Sainathan SK, Kikuchi K, Sureban SM, et al. (2010) Reg IV regulates normal intestinal and colorectal cancer cell susceptibility to radiation-induced apoptosis. Gastroenterology 138: 616-626, 626 e611-612.
55. Bishnupuri KS, Luo Q, Murmu N, Houchen CW, Anant S, et al. (2006) Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology 130: 137-149. (Pubitemid 43049844)
56. Wang F, Xu L, Guo C, Ke A, Hu G, et al. (2011) Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer. PLoS One 6: e18434.
57. Shah N, Sukumar S (2010) The Hox genes and their roles in oncogenesis. Nat Rev Cancer 10: 361-371.
58. Kim KM, Lee EJ, Ha S, Kang SY, Jang KT, et al. (2011) Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. Am J Surg Pathol 35: 1274-1286.
59. Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, et al. (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355: 873-884. (Pubitemid 44315980)
60. Meyskens FL Jr, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, et al. (2008) Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) 1: 32-38.
61. Chan AT, Ogino S, Fuchs CS (2009) Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302: 649-658.
62. Steward WP, Brown K (2013) Cancer chemoprevention: a rapidly evolving field. Br J Cancer 109: 1-7.